Skip to main content
Log in

Growth inhibition and morphologic modulation of human fibroblastlike cells by erythromycin

  • Published:
In Vitro Aims and scope Submit manuscript

Summary

In vitro exposures of mass cultures and clones of human diploid fibroblastlike cells to erythromycin, in concentrations of 50 to 400 μg/ml, result in increasing degrees of growth inhibition and augmented cell volume, with a shift toward larger proportions of cells of the epithelioid type and fewer of the fibroblast type. These alterations were reversed upon subculture in the absence of the antibiotic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Teroka, H.. Reversal of the inhibitory action of chloramphenicol on the ribosomal peptidyl transfer reaction by erythromycin. Biochem. Biophys. Acta 213: 535–536; 1970.

    Google Scholar 

  2. Clark-Walker, G. D.; Linnane, A..In vivo differentiation yeast cytoplasmic and mitochondrial protein synthesis with antibiotics. Biochem. Biophys. Res. Commun. 25: 8–13; 1967.

    Article  Google Scholar 

  3. Adoutte, A.; Beisson, J.. Cytoplasmic inheritance of erythromycin resistant mutations inParamecium aurelia. Molec. Gen. Genet. 108: 70–77; 1970.

    Article  PubMed  CAS  Google Scholar 

  4. Beale, G.; Knowles, A; Tait, A.. Mitochondrial genetics inParamecium. Nature 235: 396–397; 1972.

    Article  PubMed  CAS  Google Scholar 

  5. Pious, D. A.; Hawley, P. Effect of antibiotics on respiration in human cells. Pediat. Res. 6: 687–692; 1972.

    Article  PubMed  CAS  Google Scholar 

  6. Gray, J. E.; Purmalis, A.; Purmalis, B.; Mathews, J. Ultrastructural studies of the hepatic changes brought about by clindamycin and erythromycin in animals. Toxicol. App. Pharmacol. 19: 217–233; 1971.

    Article  CAS  Google Scholar 

  7. Dujovne, C. A.; Shoeman, D.; Branchine, J.; Lasagna, L. Experimental basis for the different hepatotoxicity of erythromycin preparations in man. J. Lab. Clin. Med. 79: 832–844; 1972.

    PubMed  CAS  Google Scholar 

  8. Ginsburg, H.; Lagunoff, D.. Thein vitro differentiation of mast cells. J. Cell Biol. 35: 685–697; 1967.

    Article  PubMed  CAS  Google Scholar 

  9. Kenny, G. E. Serological comparison of ten glycolytic mycoplasma species. J. Bacteriol. 98: 1044–1055; 1969.

    PubMed  CAS  Google Scholar 

  10. Martin, G. M.. Use of tris (hydroxymethyl) amino-methane buffers in cultures of diploid human fibroblasts. Proc. Soc. Exp. Bio. Med. 116: 167–171; 1964.

    CAS  Google Scholar 

  11. Puck, T. T.; Marcus, P. I.; Cieciura, S. J. Clonal growth of mammalian cellsin vitro. J. Exp. Med. 103: 273–283; 1956.

    Article  PubMed  CAS  Google Scholar 

  12. Klinger, H. P.; Hammond, D. O.. Rapid chromosome and sex chromatin staining with pinocyanol. Stain Technol. 46: 43–47; 1971.

    PubMed  CAS  Google Scholar 

  13. Folkman, J.; Moscona, A.. Role of cell shape in growth control. Nature 273: 345–349; 1978.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This research was supported by National Institutes of Health grants AG 00257 and RR 08139 (Division of Research Resources and National Institute on Aging) and National Science Foundation grant PCM-8003728.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martinez, A.O., Norwood, T.H. & Martin, G.M. Growth inhibition and morphologic modulation of human fibroblastlike cells by erythromycin. In Vitro 17, 979–984 (1981). https://doi.org/10.1007/BF02618422

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02618422

Key words

Navigation